Patents by Inventor Viktoria REINMUELLER
Viktoria REINMUELLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240140895Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.Type: ApplicationFiled: August 23, 2019Publication date: May 2, 2024Applicant: XENIOPRO GmbHInventors: Viktoria REINMÜLLER, Roman MARTY, Olivier WAGNIÈRES, Jean-Baptiste GUALTIEROTTI, Verena KÜPPERS
-
Publication number: 20230406814Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.Type: ApplicationFiled: December 12, 2022Publication date: December 21, 2023Applicant: XENIOPRO GMBHInventor: Viktoria REINMÜLLER
-
Publication number: 20230150923Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.Type: ApplicationFiled: December 12, 2022Publication date: May 18, 2023Applicant: XENIOPRO GMBHInventor: Viktoria REINMÜLLER
-
Publication number: 20230141913Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.Type: ApplicationFiled: August 23, 2019Publication date: May 11, 2023Applicant: XENIOPRO GmbHInventors: Viktoria REINMÜLLER, Roman MARTY, Olivier WAGNIÉRES, Jean-Baptiste GUALTIEROTTI, Verena KÜPPERS
-
Patent number: 11591289Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.Type: GrantFiled: February 26, 2018Date of Patent: February 28, 2023Assignee: Xeniopro GmbHInventor: Viktoria Reinmüller
-
Publication number: 20220354949Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.Type: ApplicationFiled: August 23, 2019Publication date: November 10, 2022Applicant: XENIOPRO GmbHInventors: Viktoria REINMÜLLER, Roman MARTY, Olivier WAGNIÈRES, Jean-Baptiste GUALTIEROTTI, Verena KÜPPERS
-
Publication number: 20220348535Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.Type: ApplicationFiled: February 26, 2018Publication date: November 3, 2022Applicant: XENIOPRO GMBHInventor: Viktoria REINMÜLLER
-
Publication number: 20220249500Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.Type: ApplicationFiled: August 23, 2019Publication date: August 11, 2022Applicant: XENIOPRO GmbHInventors: Viktoria REINMÜLLER, Roman MARTY, Olivier WAGNIÈRES, Jean-Baptiste GUALTIEROTTI, Verena KÜPPERS
-
Publication number: 20210382038Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.Type: ApplicationFiled: June 22, 2021Publication date: December 9, 2021Inventors: Freddy RADTKE, Rajwinder LEHAL, Viktoria REINMÜLLER, Jieping ZHU
-
Patent number: 11085918Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.Type: GrantFiled: March 25, 2019Date of Patent: August 10, 2021Assignee: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)Inventors: Freddy Radtke, Rajwinder Lehal, Viktoria Reinmüller, Jieping Zhu
-
Publication number: 20210107863Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.Type: ApplicationFiled: February 26, 2018Publication date: April 15, 2021Applicant: XENIOPRO GMBHInventor: Viktoria REINMÜLLER
-
Publication number: 20200360355Abstract: The present invention relates to the use for enhancing Notch signaling in an individual, of a compound showing the general formula (I) and/or a pharmaceutically acceptable salt or ester thereof, for the treatment of a disease selected from the group of dermatological disorders including atopic dermatitis, psoriasis, immune related disorders, cancer, squamous cell carcinoma, cutaneous and lung squamous cell carcinoma, head and neck cancer, non-melanoma skin cancer, basal cell carcinoma and actinic keratosis, neuroendocrine tumors, neuroendocrine small cell carcinoma and carcinoid tumors, thyroid carcinomas, muscular disorders muscular dystrophy and impaired regeneration capacity after injury; use in immunotherapy for cancer.Type: ApplicationFiled: July 24, 2020Publication date: November 19, 2020Applicant: XENIOPRO GmbHInventors: Viktoria REINMUELLER, Jieping ZHU
-
Patent number: 10772876Abstract: The present invention relates to the use for enhancing Notch signaling in an individual, of a compound showing the general formula (I) and/or a pharmaceutically acceptable salt or ester thereof, for the treatment of a disease selected from the group of dermatological disorders including atopic dermatitis, psoriasis, immune related disorders, cancer, squamous cell carcinoma, cutaneous and lung squamous cell carcinoma, head and neck cancer, non-melanoma skin cancer, basal cell carcinoma and actinic keratosis, neuroendocrine tumors, neuroendocrine small cell carcinoma and carcinoid tumors, thyroid carcinomas, muscular disorders muscular dystrophy and impaired regeneration capacity after injury; use in immunotherapy for cancer.Type: GrantFiled: March 17, 2017Date of Patent: September 15, 2020Assignee: Xeniopro GmbHInventors: Viktoria Reinmueller, Jieping Zhu
-
Publication number: 20200031763Abstract: The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the hematopoietic system including the hematologic system in human and veterinary medicine.Type: ApplicationFiled: February 26, 2018Publication date: January 30, 2020Applicant: XENIOPRO GMBHInventor: Viktoria REINMÜLLER
-
Publication number: 20190219566Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.Type: ApplicationFiled: March 25, 2019Publication date: July 18, 2019Applicant: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)Inventors: Freddy RADTKE, Rajwinder LEHAL, Viktoria REINMÜLLER, Jieping ZHU
-
Patent number: 10274481Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.Type: GrantFiled: February 8, 2016Date of Patent: April 30, 2019Assignee: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)Inventors: Freddy Radtke, Rajwinder Lehal, Viktoria Reinmüller, Jieping Zhu
-
Publication number: 20190083476Abstract: The present invention relates to the use for enhancing Notch signaling in an individual, of a compound showing the general formula (I) and/or a pharmaceutically acceptable salt or ester thereof, for the treatment of a disease selected from the group of dermatological disorders including atopic dermatitis, psoriasis, immune related disorders, cancer, squamous cell carcinoma, cutaneous and lung squamous cell carcinoma, head and neck cancer, non-melanoma skin cancer, basal cell carcinoma and actinic keratosis, neuroendocrine tumors, neuroendocrine small cell carcinoma and carcinoid tumors, thyroid carcinomas, muscular disorders muscular dystrophy and impaired regeneration capacity after injury; use in immunotherapy for cancer.Type: ApplicationFiled: March 17, 2017Publication date: March 21, 2019Applicant: XENIOPRO GmbHInventors: Viktoria REINMUELLER, Jieping ZHU
-
Patent number: 10054581Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.Type: GrantFiled: March 14, 2018Date of Patent: August 21, 2018Assignee: Ecole Polytechnique Federale de Lausanne (EPFL)Inventors: Freddy Radtke, Rajwinder Lehal, Viktoria Reinmüller, Jieping Zhu
-
Publication number: 20180224429Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.Type: ApplicationFiled: March 14, 2018Publication date: August 9, 2018Inventors: Freddy RADTKE, Rajwinder LEHAL, Viktoria REINMÜLLER, Jieping ZHU
-
Publication number: 20160266095Abstract: The present invention relates to use of inhibitors of Notch signalling pathway selected from the group consisting of 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine (I3), its derivatives, in treating and/or preventing cancers.Type: ApplicationFiled: February 8, 2016Publication date: September 15, 2016Inventors: Freddy RADTKE, Rajwinder LEHAL, Viktoria REINMÜLLER, Jieping ZHU